Cell and Tissue Preservation Market expanding growth at a CAGR of 11% from 2023 to 2032, owing to rising prevalence of injuries | insightSLICE
The global Cell and Tissue Preservation market size was estimated to be US$ 3.36 billion in 2021 and is expected grow at a CAGR of 11% between 2023 to 2032.
Global Cell and Tissue Preservation Market Report will give shares, statistics, prospects, and forecasts for the year 2023-2032. The forecast period for this period runs from 2023 to 2032, and 2021 serves as a historic period.
Access the sample report: https://www.insightslice.com/request-sample/877
The study also considers the market’s competitive environment, and the report will give an overview of the major competitors in the cell and tissue preservation market as well as their market forecasts.
In addition, the report will include information on important advancements, regional and global sales subsidiaries, business models, innovations and basic research, and major strategies for all significant market participants.
The key players of the Global Cell and Tissue Preservation Market are:
The key players of the Cell and Tissue Preservation Market are Cytiva, Avantor Inc., Merck KGaA, CellGenix GmbH, BD, Agilent Technologies, Inc., Lonza, FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, Corning Incorporated, STEMCELL Technologies Inc., LGC SeraCare, and others.
Uses of cell and tissue preservation techniques:
Currently, used methods for preserving cells and tissues include cryopreservation, deep freezing, and freeze-drying. For tendon and meniscal allografts, deep freezing is a common preservation method that essentially freezes the tissue to 80 °C.
This method aids in the preservation of a few cells and extends their useful life by an additional ten years. To freeze cells, various medium or serum types are used. The two most frequently used alternatives are glycerol and dimethyl sulfoxide (DMSO).
Proceed to purchase: https://www.insightslice.com/buy-now/877
Cells are fixed and frozen in liquid nitrogen warmer using a mixture of glycerol, dimethyl sulfoxide, serum, and medium.
In order to maintain the organic material’s viability, prevent ice crystal formation, and preserve the organic material biologically dormant, cryopreservation involves freezing cells and tissues at cold temperatures. These may disturb the lining of the cell or tissue, which will cause the cell to die.
Samples are cryopreserved to prevent cell defiling and to restrict hereditary alteration. Microorganisms, tissue cells, established cell lines, and small multicellular organisms, including complex cellular components comprising embryos, creatures, nucleic acids, and proteins are all preserved by cryopreservation.
Driving factors for the growth of Global Cell and Tissue Preservation Market
One of the important industries where important key players are starting financial investments is bio preservation, which is ultimately assisting the growth of the cell and tissue preservation market.
End-users of the market, including urgent care centres, gene banks, and biobanks, are motivating industry participants to advance the investigation and advancement of cutting-edge approaches to boost patient outcomes.
The market’s growth has been energized by the drug companies’ growing investment in the financing of preservation hardware and its acceptance. Throughout the projection period mentioned above, North America is anticipated to dominate the cell and tissue preservation market.
Asia Pacific and Europe are other notable regions that have made a substantial contribution to the growth of the cell and tissue preservation industry.
Growing patient populations and the increased proportion in the need for treatment of chronic illnesses have combined to increase the desire for cell and tissue preservation solutions. The market for cell and tissue preservation is predicted to be dominated by the tissue type segment.
Read more about the report inclusions: https://www.insightslice.com/cell-and-tissue-preservation-market
The public sector’s promotion of innovation through grants and prizes to support R&D efforts by various universities and organizations is another factor supporting the growth of the global market.
The market’s growth between 2023 and 2032 will likely be fueled by the advantages of cell preservation for use in drug development or other initiatives.
It is also anticipated that the distribution of cutting-edge as well as novel cryopreservation systems and the approval of cryopreserved cells through administrative experts would greatly foster market growth.
Global Cell and Tissue Preservation Market Key Segments:
Based on product
- Equipment
- Freezers
- Refrigerators
- Consumables
- Vials
- Straws
- Microtiter Plates
- Bags
- Liquid Nitrogen
- Media
- Pre-formulated
- Home-brew
- Laboratory Information Management System (LIMS)
- others
Based on application
- Regenerative Medicine
- Cell therapy
- Gene therapy
- Others
- Bio-banking
- Human eggs
- Human sperms
- Veterinary IVF
- Drug Discovery
- Others
Based on cell provider
- CD34+
- CD19+
- MSC
- iPSC
- hESC
- Tumor Cells
- Others
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- South Africa
- Saudi Arabia
- Rest of Middle East & Asia
- South America
- Brazil
- Rest of South America
Forecast for cell and tissue preservation market looks good:
Growing demand for medical services is a significant driver of this industry. Spending on medical services has increased as a result of rapid global financial development.
Increased use of medical services is predicted to increase access to high-quality medical treatment and cutting-edge procedures that use bio preservation organizations, thus extending development opportunities.
Biobanks exhibit a positive growth rate during the projection period in terms of end users. The biobanks store distinctive biospecimens. These samples contain organs, appendages, cells, tissues, etc. As a result, these elements support the growth of the biobanks marketplace in the cell and tissue preservation sector.
A decline in fertility rate, favorable government initiatives to support research projects in the pharmaceutical and biopharmaceutical industries, and producers’ focus on improving novel products for cell preservation are some of the factors driving the growth of the cryopreservation of cells market in the past few years.
Related reports:
Global Hematology Drugs Market: https://www.insightslice.com/hematology-drugs-market
Global Medical and Diagnostic Laboratory Services Market: https://www.insightslice.com/medical-and-diagnostic-laboratory-services-market
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
